Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 5

1.

Remodeling specific immunity by use of MHC tetramers: demonstration in a graft-versus-host disease model.

Kappel BJ, Pinilla-Ibarz J, Kochman AA, Eng JM, Hubbard VM, Leiner I, Pamer EG, Heller G, van den Brink MR, Scheinberg DA.

Blood. 2006 Mar 1;107(5):2045-51. Epub 2005 Nov 3.

2.

[MHC tetramers: tracking specific immunity].

Kosor E, Gagro A, Drazenović V, Kuzman I, Jeren T, Rakusić S, Rabatić S, Markotić A, Gotovac K, Sabioncello A, Cecuk E, Kerhin-Brkljacić V, Gjenero-Margan I, Kaić B, Mlinarić-Galinović G, Kastelan A, Dekaris D.

Acta Med Croatica. 2003;57(4):255-9. Review. Croatian.

PMID:
14639858
3.

Bone marrow transplantation for chronic myeloid leukemia with volunteer unrelated donors using ex vivo or in vivo T-cell depletion: major prognostic impact of HLA class I identity between donor and recipient.

Spencer A, Szydlo RM, Brookes PA, Kaminski E, Rule S, van Rhee F, Ward KN, Hale G, Waldmann H, Hows JM, Batchelor JR, Goldman JM.

Blood. 1995 Nov 1;86(9):3590-7. Review.

4.

Alloimmune T cells in transplantation.

DeWolf S, Sykes M.

J Clin Invest. 2017 Jun 30;127(7):2473-2481. doi: 10.1172/JCI90595. Epub 2017 Jun 19. Review.

5.

Major histocompatibility complex (MHC) tetramer technology: an evaluation.

Constantin CM, Bonney EE, Altman JD, Strickland OL.

Biol Res Nurs. 2002 Oct;4(2):115-27. Review.

PMID:
12408217

Supplemental Content

Support Center